Transforming Women’s Health Through Science, Action, and CollaborationTogether with communities, researchers, health care providers, and policymakers, WINGS-4-FGS is finding ways to effectively detect and treat the neglected disease Female Genital Schistosomiasis (FGS) and giving women and girls the health and dignity they deserve.Discover Our Story
Transforming Women’s Health Through Science, Action, and CollaborationTogether with communities, researchers, health care providers, and policymakers, WINGS-4-FGS is finding ways to effectively detect and treat the neglected disease Female Genital Schistosomiasis (FGS) and giving women and girls the health and dignity they deserve.Discover Our Story
ENEN
FRFR

Kamuzu University of Health Sciences

Kamuzu University of Health Sciences (KUHeS) is a comprehensive higher learning public institution for health and allied sciences in Malawi, Southern Africa, imparting knowledge and transferable skills through teaching and learning, research, consultancy and application to meet professional needs at all levels. It was established in 2019 under the act of Malawi Parliament by merging Kamuzu College of Nursing (est. 1965) and College of Medicine (est. 1991), gazetted on 4th May 2021.

Recognized as a leading institution, ranking among the top 5 academic institutions in Africa for health sciences research by the Nature Index 2025, KUHeS trains diverse health workers, including medical doctors, nurses, midwives, pharmacists, laboratory technologists, biomedical scientists, physiotherapists and nutritionists at both undergraduate and postgraduate levels with a focus on global standards and local relevance. These trainings are provided through the five schools in KUHeS, namely School of Global and Public Health, School of Life Sciences and Allied Health Professions, School of Nursing, School of Maternal, Neonatal and Reproductive Health and School of Medicine and Oral Health.

In addition, KUHeS has affiliated organizations including Malawi Liverpool Wellcome Research Programme (MLW) which is a prestigious research and training institution established in 1995 in partnership with Liverpool School of Tropical Medicine (LSTM), University of Liverpool, and Wellcome Trust UK. MLW delivers groundbreaking research, shaping global health policy through 6 research themes, namely, infection biology, vaccines, population health, clinical and experimental medicine, maternal neonatal and child health, and social sciences; 22 research groups and associate research groups which collaborate in support with the operations, spanning from laboratory-based and clinical trials to community-level studies and research support units.

Role within WINGS-4-FGS

Female Genital Schistosomiasis (FGS), a consequence of schistosomiasis caused by the parasite Schistosoma haematobium, remains a debilitating disease affecting millions of women and girls in Malawi and other sub-Saharan African countries, leading to significant morbidity and reproductive health issues. At least, 56 million women and girls are affected with FGS globally, more disproportionately in endemic areas like Malawi which show significant prevalences of FGS of over 20%.

KUHeS is part of the consortium of WINGS-4-FGS and one of the 4 countries in sub-Saharan Africa region conducting the scientific field activities for the project. KUHeS will lead the implementation of Work Package 2 which is focused on the community diagnosis of FGS using a 2-step approach. Alongside this WP2, it will also lead the clinical trial on the treatment and resolution of FGS lesions among affected women in WP3.